GMO Research & AI, Inc. Logo

GMO Research & AI, Inc.

Market research tech providing access to 65M+ APAC consumer panelists for data-driven insights.

3695 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
渋谷区桜丘町26番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

GMO Research & AI, Inc. is a market research technology company specializing in the Asia-Pacific region. Through its Asia Cloud Panel, an online audience engagement platform, the company provides access to over 65 million consumer panelists across 14 APAC markets. As Japan's leading consumer panel provider, GMO Research & AI offers comprehensive sampling solutions for consumer, B2B, and healthcare sectors. The firm leverages deep regional, cultural, and linguistic expertise to deliver reliable, localized data and actionable insights, enabling global clients to make informed, data-driven decisions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 04:59
Report Publication Announcement
確認書
Japanese 9.0 KB
2025-08-13 04:57
Interim Report
半期報告書-第24期(2025/01/01-2025/12/31)
Japanese 254.0 KB
2025-05-19 09:11
Registration Form
臨時報告書
Japanese 35.5 KB
2025-03-19 05:04
Regulatory News Service
臨時報告書
Japanese 29.4 KB
2025-03-19 03:13
Regulatory News Service
確認書
Japanese 9.4 KB
2025-03-19 03:11
Regulatory News Service
内部統制報告書-第23期(2024/01/01-2024/12/31)
Japanese 24.8 KB
2025-03-19 03:09
Annual Report
有価証券報告書-第23期(2024/01/01-2024/12/31)
Japanese 1.3 MB
2025-02-12 07:40
Regulatory News Service
臨時報告書
Japanese 173.9 KB
2024-08-09 06:15
Regulatory News Service
確認書
Japanese 9.4 KB
2024-08-09 06:14
Interim Report
半期報告書-第23期(2024/01/01-2024/12/31)
Japanese 203.1 KB
2024-05-13 04:45
Regulatory News Service
確認書
Japanese 9.5 KB
2024-05-13 04:45
Quarterly Report
四半期報告書-第23期第1四半期(2024/01/01-2024/03/31)
Japanese 160.7 KB
2024-03-19 03:42
Registration Form
確認書
Japanese 8.9 KB
2024-03-19 03:39
Governance Information
内部統制報告書-第22期(2023/01/01-2023/12/31)
Japanese 24.0 KB
2024-03-19 03:37
Registration Form
有価証券報告書-第22期(2023/01/01-2023/12/31)
Japanese 1.3 MB

Automate Your Workflow. Get a real-time feed of all GMO Research & AI, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GMO Research & AI, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway PCIB

Talk to a Data Expert

Have a question? We'll get back to you promptly.